Mental health advocates are lobbying Congress to help them get schizophrenia classified as a brain disease like Parkinson or Alzheimer disease, instead of as a mental illness; the annual Consumer Electronics Show, which begins this week in Las Vegas, has become an increasingly popular place for health technology firms looking for publicity in the $7 trillion global medical industry; the Trump administration warned scientists doing biomedical research at American universities that Chinese spies may be trying to steal and exploit information.
Mental health advocates are lobbying Congress to help them get schizophrenia classified as a brain disease like Parkinson or Alzheimer disease, instead of as a mental illness, Politico reported. The Schizophrenia and Related Disorders Alliance of America is among those pushing Congress to include schizophrenia in a new CDC program that aims to collect data on the prevalence and risk factors of neurological conditions in the United States, a move that could reduce stigma and lead to more funding for a cure. The problem is that the CDC only has enough money to study a finite number of conditions, putting disease advocacy groups in competition with each other.
The annual Consumer Electronics Show, which begins this week in Las Vegas, has become an increasingly popular place for health technology firms looking for publicity in the $7 trillion global medical industry, STAT News reported. This year brings a particular focus on chronic disease, but some experts warn that the real-world results of digital health products have not caught up to their promises. Companies will feature products targeting heart monitoring, diabetes, and nonopioid management of chronic pain.
The Trump administration warned scientists doing biomedical research at American universities that Chinese spies may be trying to steal and exploit information, The New York Times reported. Scientists and universities receiving National Institutes of Health funding need to tighten their security procedures and take other precautions, said a panel of experts commissioned by the agency to investigate “foreign influences on research integrity.”
Urticaria Diagnosis Challenged by Overlapping Pruritic Skin Conditions
April 23rd 2025Urticaria is complicated to diagnose by its symptomatic overlap with other skin conditions and the frequent misclassification in literature of distinct pathologies like vasculitic urticaria and bullous pemphigus.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
ACOs’ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz
April 23rd 2025Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Read More